Please make a donation to the Aplastic Anemia and MDS International Foundation this holiday season.
Dr. Satheesh Chonat explains how pediatric patients with PNH, or Paroxysmal Nocturnal Hemoglobinuria, may be treated with PiaSky in this recording. Listen now or read transcript below.
Dr. Carlos DeCastro reviews how PiaSky can be used to treat patients with PNH, or Paroxysmal Nocturnal Hemoglobinuria. Listen or read the transcript below.
In this webinar, Dr. Andrew Matthews discusses Low Risk MDS, current treatments and what's on the treatment horizon. Dr. Matthews took many questions from the live audience.
David Hermel, MD, is a hematologist and medical oncologist who specializes in malignant hematology with an interest in the use of novel therapies, such as cellular immunotherapy and
Dr. Rory Shallis explains the treatment, Imetelstat, for patients with Low Risk MDS. Listen or read the transcript below.
MINNEAPOLIS, June 14, 2024 — NMDPSM, a global nonprofit leader in cell therapy, and the CIBMTR® (Center for International Blood and Marrow Transplant Research®) announced interim results from the ACCESS trial as an oral abstract during the European Hematology Association (EHA) Annual Meeting in Madrid, Spain.
